Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

How macrophages deal with death.

Lemke G.

Nat Rev Immunol. 2019 Apr 24. doi: 10.1038/s41577-019-0167-y. [Epub ahead of print] Review.

PMID:
31019284
2.

TAM Receptors in Cardiovascular Disease.

McShane L, Tabas I, Lemke G, Kurowska-Stolarska M, Maffia P.

Cardiovasc Res. 2019 Apr 13. pii: cvz100. doi: 10.1093/cvr/cvz100. [Epub ahead of print]

PMID:
30980657
3.

Poor return on investment: investigating the barriers that cause low credentialing yields in a resource-limited clinical ultrasound training programme.

Lamprecht H, Lemke G, van Hoving D, Kruger T, Wallis L.

Int J Emerg Med. 2018 Feb 21;11(1):11. doi: 10.1186/s12245-018-0168-9.

4.

Phosphatidylserine Is the Signal for TAM Receptors and Their Ligands.

Lemke G.

Trends Biochem Sci. 2017 Sep;42(9):738-748. doi: 10.1016/j.tibs.2017.06.004. Epub 2017 Jul 19. Review.

5.

MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis.

Kurowska-Stolarska M, Alivernini S, Melchor EG, Elmesmari A, Tolusso B, Tange C, Petricca L, Gilchrist DS, Di Sante G, Keijzer C, Stewart L, Di Mario C, Morrison V, Brewer JM, Porter D, Milling S, Baxter RD, McCarey D, Gremese E, Lemke G, Ferraccioli G, McSharry C, McInnes IB.

Nat Commun. 2017 Jun 22;8:15877. doi: 10.1038/ncomms15877.

6.

A molecular mechanism for the topographic alignment of convergent neural maps.

Savier E, Eglen SJ, Bathélémy A, Perraut M, Pfrieger FW, Lemke G, Reber M.

Elife. 2017 Mar 14;6. pii: e20470. doi: 10.7554/eLife.20470.

7.

Phosphatidylserine Exposure Controls Viral Innate Immune Responses by Microglia.

Tufail Y, Cook D, Fourgeaud L, Powers CJ, Merten K, Clark CL, Hoffman E, Ngo A, Sekiguchi KJ, O'Shea CC, Lemke G, Nimmerjahn A.

Neuron. 2017 Feb 8;93(3):574-586.e8. doi: 10.1016/j.neuron.2016.12.021. Epub 2017 Jan 19.

8.

TAM receptors regulate multiple features of microglial physiology.

Fourgeaud L, Través PG, Tufail Y, Leal-Bailey H, Lew ED, Burrola PG, Callaway P, Zagórska A, Rothlin CV, Nimmerjahn A, Lemke G.

Nature. 2016 Apr 14;532(7598):240-244. doi: 10.1038/nature17630. Epub 2016 Apr 6.

9.

Adopting ALK and LTK.

Lemke G.

Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15783-4. doi: 10.1073/pnas.1521923113. Epub 2015 Dec 16. No abstract available.

10.

The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity.

Miner JJ, Daniels BP, Shrestha B, Proenca-Modena JL, Lew ED, Lazear HM, Gorman MJ, Lemke G, Klein RS, Diamond MS.

Nat Med. 2015 Dec;21(12):1464-72. doi: 10.1038/nm.3974. Epub 2015 Nov 2.

11.

Monoclonal 1- and 3-Phosphohistidine Antibodies: New Tools to Study Histidine Phosphorylation.

Fuhs SR, Meisenhelder J, Aslanian A, Ma L, Zagorska A, Stankova M, Binnie A, Al-Obeidi F, Mauger J, Lemke G, Yates JR 3rd, Hunter T.

Cell. 2015 Jul 2;162(1):198-210. doi: 10.1016/j.cell.2015.05.046.

12.

Mer receptor tyrosine kinase mediates both tethering and phagocytosis of apoptotic cells.

Dransfield I, Zagórska A, Lew ED, Michail K, Lemke G.

Cell Death Dis. 2015 Feb 19;6:e1646. doi: 10.1038/cddis.2015.18.

13.

A ligand for ALK.

Lemke G, Lew ED.

Sci Signal. 2015 Jan 20;8(360):fs2. doi: 10.1126/scisignal.aaa5566.

PMID:
25605971
14.

Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.

Lew ED, Oh J, Burrola PG, Lax I, Zagórska A, Través PG, Schlessinger J, Lemke G.

Elife. 2014 Sep 29;3. doi: 10.7554/eLife.03385.

15.

Stephen F. Heinemann: A true original.

Lemke G, Julius D.

Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14314-5. doi: 10.1073/pnas.1416208111. Epub 2014 Sep 25. No abstract available.

16.

Diversification of TAM receptor tyrosine kinase function.

Zagórska A, Través PG, Lew ED, Dransfield I, Lemke G.

Nat Immunol. 2014 Oct;15(10):920-8. doi: 10.1038/ni.2986. Epub 2014 Sep 7.

17.

Biology of the TAM receptors.

Lemke G.

Cold Spring Harb Perspect Biol. 2013 Nov 1;5(11):a009076. doi: 10.1101/cshperspect.a009076. Review.

18.

Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors.

Bhattacharyya S, Zagórska A, Lew ED, Shrestha B, Rothlin CV, Naughton J, Diamond MS, Lemke G, Young JA.

Cell Host Microbe. 2013 Aug 14;14(2):136-47. doi: 10.1016/j.chom.2013.07.005.

19.

T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response.

Carrera Silva EA, Chan PY, Joannas L, Errasti AE, Gagliani N, Bosurgi L, Jabbour M, Perry A, Smith-Chakmakova F, Mucida D, Cheroutre H, Burstyn-Cohen T, Leighton JA, Lemke G, Ghosh S, Rothlin CV.

Immunity. 2013 Jul 25;39(1):160-70. doi: 10.1016/j.immuni.2013.06.010. Epub 2013 Jul 11.

20.

Is the TAM receptor Axl a receptor for lymphocytic choriomeningitis virus?

Sullivan BM, Welch MJ, Lemke G, Oldstone MB.

J Virol. 2013 Apr;87(7):4071-4. doi: 10.1128/JVI.03268-12. Epub 2013 Jan 16.

21.

Genetic dissection of TAM receptor-ligand interaction in retinal pigment epithelial cell phagocytosis.

Burstyn-Cohen T, Lew ED, Través PG, Burrola PG, Hash JC, Lemke G.

Neuron. 2012 Dec 20;76(6):1123-32. doi: 10.1016/j.neuron.2012.10.015.

22.

The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry.

Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, Lew E, Lemke G, Schwartz O, Amara A.

Cell Host Microbe. 2012 Oct 18;12(4):544-57. doi: 10.1016/j.chom.2012.08.009.

23.

Identification of Axl as a downstream effector of TGF-β1 during Langerhans cell differentiation and epidermal homeostasis.

Bauer T, Zagórska A, Jurkin J, Yasmin N, Köffel R, Richter S, Gesslbauer B, Lemke G, Strobl H.

J Exp Med. 2012 Oct 22;209(11):2033-47. doi: 10.1084/jem.20120493. Epub 2012 Oct 15.

24.

Dominant-negative isoforms of Tcf/Lef proteins in development and disease.

Vacik T, Lemke G.

Cell Cycle. 2011 Dec 15;10(24):4199-200. doi: 10.4161/cc.10.24.18465. Epub 2011 Dec 15. No abstract available.

PMID:
22157225
25.

VAX1 mutation associated with microphthalmia, corpus callosum agenesis, and orofacial clefting: the first description of a VAX1 phenotype in humans.

Slavotinek AM, Chao R, Vacik T, Yahyavi M, Abouzeid H, Bardakjian T, Schneider A, Shaw G, Sherr EH, Lemke G, Youssef M, Schorderet DF.

Hum Mutat. 2012 Feb;33(2):364-8. doi: 10.1002/humu.21658. Epub 2011 Dec 27.

26.

A novel mechanism for the transcriptional regulation of Wnt signaling in development.

Vacik T, Stubbs JL, Lemke G.

Genes Dev. 2011 Sep 1;25(17):1783-95. doi: 10.1101/gad.17227011. Epub 2011 Aug 19.

27.

Transcriptome analysis of neural progenitor cells by a genetic dual reporter strategy.

Wang J, Zhang H, Young AG, Qiu R, Argalian S, Li X, Wu X, Lemke G, Lu Q.

Stem Cells. 2011 Oct;29(10):1589-600. doi: 10.1002/stem.699.

28.

Genetic dissection of EphA receptor signaling dynamics during retinotopic mapping.

Bevins N, Lemke G, Reber M.

J Neurosci. 2011 Jul 13;31(28):10302-10. doi: 10.1523/JNEUROSCI.1652-11.2011.

29.

TAM receptor signaling and autoimmune disease.

Rothlin CV, Lemke G.

Curr Opin Immunol. 2010 Dec;22(6):740-6. doi: 10.1016/j.coi.2010.10.001. Epub 2010 Oct 26. Review.

30.

TAM receptors and the clearance of apoptotic cells.

Lemke G, Burstyn-Cohen T.

Ann N Y Acad Sci. 2010 Oct;1209:23-9. doi: 10.1111/j.1749-6632.2010.05744.x.

31.

Retinal input instructs alignment of visual topographic maps.

Triplett JW, Owens MT, Yamada J, Lemke G, Cang J, Stryker MP, Feldheim DA.

Cell. 2009 Oct 2;139(1):175-85. doi: 10.1016/j.cell.2009.08.028.

32.

Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis.

Burstyn-Cohen T, Heeb MJ, Lemke G.

J Clin Invest. 2009 Oct;119(10):2942-53. doi: 10.1172/JCI39325.

33.

Disturbed distribution of proliferative brain cells during lupus-like disease.

Stanojcic M, Burstyn-Cohen T, Nashi N, Lemke G, Sakic B.

Brain Behav Immun. 2009 Oct;23(7):1003-13. doi: 10.1016/j.bbi.2009.05.061. Epub 2009 Jun 6.

34.

The PI3K-PTEN tug-of-war, oxidative stress and retinal degeneration.

Kang KH, Lemke G, Kim JW.

Trends Mol Med. 2009 May;15(5):191-8. doi: 10.1016/j.molmed.2009.03.005. Epub 2009 Apr 18.

35.

Retinal degeneration triggered by inactivation of PTEN in the retinal pigment epithelium.

Kim JW, Kang KH, Burrola P, Mak TW, Lemke G.

Genes Dev. 2008 Nov 15;22(22):3147-57. doi: 10.1101/gad.1700108. Epub 2008 Nov 7.

36.

Isolation and analysis of the gene encoding peripheral myelin protein zero.

Lemke G.

Neuron. 2008 Nov 6;60(3):403. doi: 10.1016/j.neuron.2008.10.034. No abstract available.

37.

Axl and Tyro3 modulate female reproduction by influencing gonadotropin-releasing hormone neuron survival and migration.

Pierce A, Bliesner B, Xu M, Nielsen-Preiss S, Lemke G, Tobet S, Wierman ME.

Mol Endocrinol. 2008 Nov;22(11):2481-95. doi: 10.1210/me.2008-0169. Epub 2008 Sep 11.

38.

Immunobiology of the TAM receptors.

Lemke G, Rothlin CV.

Nat Rev Immunol. 2008 May;8(5):327-36. doi: 10.1038/nri2303. Review.

39.

Segregation of axial motor and sensory pathways via heterotypic trans-axonal signaling.

Gallarda BW, Bonanomi D, Müller D, Brown A, Alaynick WA, Andrews SE, Lemke G, Pfaff SL, Marquardt T.

Science. 2008 Apr 11;320(5873):233-6. doi: 10.1126/science.1153758.

40.

Eph receptors and ephrin ligands in axon guidance.

Reber M, Hindges R, Lemke G.

Adv Exp Med Biol. 2007;621:32-49. doi: 10.1007/978-0-387-76715-4_3. Review. No abstract available.

PMID:
18269209
41.

Role of Gas6 in erythropoiesis and anemia in mice.

Angelillo-Scherrer A, Burnier L, Lambrechts D, Fish RJ, Tjwa M, Plaisance S, Sugamele R, DeMol M, Martinez-Soria E, Maxwell PH, Lemke G, Goff SP, Matsushima GK, Earp HS, Chanson M, Collen D, Izui S, Schapira M, Conway EM, Carmeliet P.

J Clin Invest. 2008 Feb;118(2):583-96. doi: 10.1172/JCI30375.

42.

TAM receptors are pleiotropic inhibitors of the innate immune response.

Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G.

Cell. 2007 Dec 14;131(6):1124-36.

43.

SREBP-1c expression in Schwann cells is affected by diabetes and nutritional status.

de Preux AS, Goosen K, Zhang W, Sima AA, Shimano H, Ouwens DM, Diamant M, Hillebrands JL, Rozing J, Lemke G, Beckmann JS, Smit AB, Verheijen MH, Chrast R.

Mol Cell Neurosci. 2007 Aug;35(4):525-34. Epub 2007 May 1.

PMID:
17632011
44.

Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.

Seitz HM, Camenisch TD, Lemke G, Earp HS, Matsushima GK.

J Immunol. 2007 May 1;178(9):5635-42.

45.

Stromal-cell regulation of natural killer cell differentiation.

Roth C, Rothlin C, Riou S, Raulet DH, Lemke G.

J Mol Med (Berl). 2007 Oct;85(10):1047-56. Epub 2007 Apr 11. Review.

PMID:
17426948
46.

A critical role for the EphA3 receptor tyrosine kinase in heart development.

Stephen LJ, Fawkes AL, Verhoeve A, Lemke G, Brown A.

Dev Biol. 2007 Feb 1;302(1):66-79. Epub 2006 Aug 30.

47.

Hedgehog-regulated localization of Vax2 controls eye development.

Kim JW, Lemke G.

Genes Dev. 2006 Oct 15;20(20):2833-47.

48.

TAM receptor function in the retinal pigment epithelium.

Prasad D, Rothlin CV, Burrola P, Burstyn-Cohen T, Lu Q, Garcia de Frutos P, Lemke G.

Mol Cell Neurosci. 2006 Sep;33(1):96-108. Epub 2006 Aug 9.

PMID:
16901715
49.

Twist mediates suppression of inflammation by type I IFNs and Axl.

Sharif MN, Sosic D, Rothlin CV, Kelly E, Lemke G, Olson EN, Ivashkiv LB.

J Exp Med. 2006 Aug 7;203(8):1891-901. Epub 2006 Jul 10.

50.

Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases.

Caraux A, Lu Q, Fernandez N, Riou S, Di Santo JP, Raulet DH, Lemke G, Roth C.

Nat Immunol. 2006 Jul;7(7):747-54. Epub 2006 Jun 4.

PMID:
16751775

Supplemental Content

Support Center